Investor Relations
Why Invest in Sun
Sunshine Holdings PLC offers a unique investment opportunity across Healthcare, Consumer, and Agribusiness. A fully integrated healthcare segment, complemented by strong market positions within the consumer segment, makes SUN a defensive portfolio with sustainable growth prospects. Backed by a solid financial position, disciplined capital management, and a commitment to sustainable and ethical practices, SUN continues to deliver long-term value to all its stakeholders.
Key Highlights
Total revenue bysectors
1QFY27 (APRIL - JUNE)
Agri
Consumer
No Data Found
Healthcare
No Data Found
Agri
Consumer
Healthcare
market cap
key statistics
LKR
1QFY27
-7.7%
YoY
1QFY27
6.0%
YoY
LKR
1QFY27
-1.9%
YoY
LKR
1QFY27
-1.4%
YoY
LKR
1QFY27
1QFY27
-0.6
pts YoY
1QFY27
+10.4
pts YoY
1QFY27
-7.7%
YoY
1QFY27
6.0%
YoY
1QFY27
-1.9%
YoY
1QFY27
-1.4%
YoY
FY27YTD
+84.6%
YoY
1QFY27
-2.6%
pts YoY
1QFY27
+10.4%
pts YoY
share price
stock market
Real-Time Share Insights
Stay informed with real-time updates of Sunshine Holdings’ share price and market performance on the Colombo Stock Exchange. View live stock charts, daily movements, and trading insights — helping you track value creation and make informed decisions.
Financial reports
Unlocking Value ThroughInvestor Insights
Quarterly Reports 2026/27
Investor Webinar and Presentation
4QFY23
3QFY23
2QFY23
1QFY23
4QFY22
3QFY22
2QFY22
1QFY22
4QFY21
3QFY21
2QFY21
1QFY21
4QFY20
3QFY20
2QFY20
1QFY20
4QFY19
3QFY19
2QFY19
1QFY19
Financial Calender
Count Down to Key Events
Result Release
Q2 Results Release
FY27
30
2026
Q2
Q3 Results Release
FY27
05
2027
Q3
Q4 Results Release
FY27
28
2027
Q4
Q1 Results Release
FY28
30
2027
Q4
Disclosure – Dates are indicative and subject to change.
Events and notices
Sunshine Healthcare Lanka Limited (a subsidiary of Sunshine Holdings PLC) entered into a 50:50 joint venture with India's Zydus Lifesciences Limited to establish Zydus Sunshine Lifesciences (Private) Limited, which will develop and operate a GMP-compliant oral solid dosage pharmaceutical manufacturing facility in the Horana BOI Export Processing Zone, with a total estimated project cost of USD 20 Mn.
JAPC Acquisition
Sunshine Holdings PLC entered into a share sale and purchase agreement to acquire 577,320 shares of Joint Agri Products Ceylon (Private) Limited (JAPC) for LKR 2.7bn, resulting in an effective 75% stake post-restructuring, expanding its Consumer sector portfolio and international market reach. Further, the Founder Shareholders will remain on the Board of JAPC, continuing their involvement in the business and operations.
Dividend Announcement
Sunshine Holdings PLC has declared a second interim dividend of Rs. 0.60 per share for FY26 (XD date – 19 Feb 2026, Payment date - 11 March 2026)
Dividend Announcement
Sunshine Holdings PLC has declared a Final dividend of Rs. 0.60 per share for FY26 (XD date – 26 June 2026, Payment date – 16 July 2026)
Dividend Announcement
Watawala Plantation PLC has declared a Final dividend of Rs. 0.80 per share for FY26 (XD date – 26 June 2026, Payment date – 16 July 2026)
sign up
Stay Connected With SUN
Signup for Investor Webinar and investor relations mails.
contact us
Connect with Our Team
For all matters related to Sunshine Holdings PLC’s financial performance, corporate disclosures, governance practices, or other investor and analyst inquiries, our Investor Relations team can be reached through the following contact details:
Investor Relations
No.60, Dharmapala Mawatha, Colombo 03, Sri Lanka.
+94 11 4 702 400